RaySearch receives first order for DrugLog
RaySearch Laboratories AB (publ) today announces that the Polish company Medim has placed an order for the product DrugLog™. The order is a result of Medim winning a tender from The Children's Memorial Health Institute in Warsaw, Poland.
DrugLog is RaySearch's cost-effective solution for quickly and efficiently verifying the identity and concentration of compounded injectable medications used, for example, in cancer treatment with with cytostatic drugs (chemotherapy). DrugLog is used to detect errors in the preparation of drugs, which reduces the risk of medication errors. DrugLog is a unique combination of cutting-edge software and reliable well-established hardware for absorption spectroscopy.
The order includes the product DrugLog and support agreements for the second and third year. The Children's Memorial Health Institute is Poland's largest and most well-equipped children's hospital and is directly subordinated to the Polish Ministry of Health. It is also one of the leading teaching hospitals in Poland.
In the beginning of 2024 RaySearch acquired the product DrugLog from Pharmacolog in Uppsala, Sweden, to complement the product offering by improving and/or simplifying quality assurance in cancer treatment with cytostatic drugs.
Medim was founded in 1990 and has extensive experience in selling products and solutions to the healthcare sector in the Polish market.
Mateusz Nejman, Director of New Technologies Department, Medim: “This is an important milestone for our partnership with RaySearch. The new customer is a proof of how our joint efforts and expertise create concrete results in the market.”
Johan Löf, founder and CEO, RaySearch: “We are pleased to announce that The Children's Memorial Health Institute in Warsaw, Poland is purchasing DrugLog. Medim is our first customer for DrugLog, which we acquired at the beginning of the year to complement our existing product offering. DrugLog represents a further step towards the vision of providing software support for all types of cancer treatments, including chemotherapy and surgery.”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
Learn more about us on:
LinkedIn
YouTube
X
About Medim
Medim is a leading Polish company with 35 years in the medical equipment industry, specializing in innovative solutions. Since its founding in 1990, it has exclusively distributed KARL STORZ Endoskope, pioneering minimally invasive and robotic surgery in Poland. Medim established the "Endoexpert" academy for training and played a key role in introducing laparoscopic and robotic surgical techniques, including the acquisition of the Da Vinci robot by Wroclaw Provincial Hospital. Today, it ranks among the top medical equipment distributors in Poland. Read more at medim.pl/eng.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch’s software has been sold to over 1,000 clinics in 44 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About DrugLog
DrugLog™ is RaySearch's cost-effective solution for quickly and efficiently verifying the identity and concentration of compounded injectable medications used, for example, in cancer treatment with with cytostatic drugs (chemotherapy). Using DrugLog reduces the risk of errors in drug preparation. In just a few seconds, the pharmacist can determine whether a diluted or prepared drug has the correct properties, ensuring accuracy in each individualized preparation. DrugLog is a unique combination of cutting-edge software and reliable well-established hardware for absorption spectroscopy.
* Subject to regulatory clearance in some markets.
Tags:
